We are live on
!
Find out more
SPA
Sherbrooke Park Advisers Portfolio holdings
AUM
$38.7M
1-Year Est. Return
5.29%
This Fund
S&P 500
This Quarter
Est. Return
+6.29%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$230M
AUM Growth
+$15.6M
(+7.3%)
Cap. Flow
+$5.46M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
6.97%
Holding
827
New
263
Increased
114
Reduced
126
Closed
324
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$1.45M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$1.42M |
| 3 |
Genpact
G
|
+$1.42M |
| 4 |
C.H. Robinson
CHRW
|
+$1.34M |
| 5 |
OGE Energy
OGE
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$1.44M |
| 2 |
Mondelez International
MDLZ
|
+$1.42M |
| 3 |
Avnet
AVT
|
+$1.21M |
| 4 |
Marvell Technology
MRVL
|
+$1.04M |
| 5 |
XYZ
Block Inc
XYZ
|
+$987K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.25% |
| 2 | Consumer Discretionary | 15.35% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 12.99% |
| 5 | Financials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XHR
401
Xenia Hotels & Resorts
XHR
$1.79B
| $190K | 0.08% |
+15,151
| New | +$173K |
|
|
MCW
402
DELISTED
Mister Car Wash
MCW
| $189K | 0.08% |
+31,414
| New | +$221K |
|
403
Fulcrum Therapeutics
FULC
$297M
| $187K | 0.08% |
27,201
-28,141
| -51% | -$151K |
|
404
SoundThinking
SSTI
$103M
| $186K | 0.08% |
14,276
-2,967
| -17% | -$46.3K |
|
405
ADMA Biologics
ADMA
$2.22B
| $183K | 0.08% |
+10,063
| New | +$205K |
|
406
Digital Turbine
APPS
$1.74B
| $183K | 0.08% |
+31,002
| New | +$127K |
|
407
Green Dot
GDOT
$745M
| $181K | 0.08% |
+16,794
| New | +$152K |
|
408
Amneal Pharmaceuticals
AMRX
$5.79B
| $180K | 0.08% |
+22,300
| New | +$168K |
|
409
Costamare
CMRE
$1.77B
| $177K | 0.08% |
19,411
-2,649
| -12% | -$23.6K |
|
410
Hecla Mining
HL
$11.3B
| $176K | 0.08% |
29,451
+11,330
| +63% | +$62.5K |
|
411
Healthcare Services Group
HCSG
$1.53B
| $176K | 0.08% |
+11,712
| New | +$155K |
|
412
10x Genomics
TXG
$6.61B
| $175K | 0.08% |
+15,142
| New | +$138K |
|
|
STKL
413
DELISTED
SunOpta
STKL
| $175K | 0.08% |
30,144
+8,939
| +42% | +$46.9K |
|
414
Empire State Realty Trust
ESRT
$836M
| $174K | 0.08% |
21,555
+7,994
| +59% | +$61.2K |
|
415
Intellia Therapeutics
NTLA
$1.67B
| $172K | 0.07% |
18,290
+894
| +5% | +$7.34K |
|
|
FOLD
416
DELISTED
Amicus Therapeutics
FOLD
| $169K | 0.07% |
29,539
+14,266
| +93% | +$92.1K |
|
|
JAMF
417
DELISTED
Jamf
JAMF
| $169K | 0.07% |
+17,784
| New | +$191K |
|
418
Ooma
OOMA
$604M
| $165K | 0.07% |
12,821
-3,123
| -20% | -$39.7K |
|
419
Prothena Corp
PRTA
$450M
| $165K | 0.07% |
+27,221
| New | +$204K |
|
|
SEMR
420
DELISTED
Semrush
SEMR
| $163K | 0.07% |
+17,965
| New | +$174K |
|
|
DAWN
421
DELISTED
Day One Biopharmaceuticals
DAWN
| $162K | 0.07% |
+24,998
| New | +$172K |
|
422
Lifestance Health
LFST
$4.14B
| $151K | 0.07% |
29,267
-7,051
| -19% | -$42.2K |
|
423
Xencor
XNCR
$1.55B
| $151K | 0.07% |
+19,236
| New | +$173K |
|
|
VERV
424
DELISTED
Verve Therapeutics
VERV
| $148K | 0.06% |
13,215
-6,618
| -33% | -$37.7K |
|
425
SunCoke Energy
SXC
$797M
| $147K | 0.06% |
17,096
-8,468
| -33% | -$73.4K |
|
Similar funds
2C
SIM
ISSM
KCM
EFI
ICM
APM
CI
Sherbrooke Park Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, Sherbrooke Park Advisers held 827 positions worth $230M, up 7.3% from $215M the previous quarter. Its ten largest holdings account for 7% of the portfolio.
Sherbrooke Park Advisers's Q2 2025 filing shows 263 new, 114 increased, 126 reduced and 324 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M. The largest sale was Merck, an estimated $1.44M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Sherbrooke Park Advisers's largest Q2 2025 buy was BioMarin Pharmaceuticals: 24,678 shares worth $1.36M.
- Sherbrooke Park Advisers added most to CMS Energy in Q2 2025, an estimated $1.14M increase.
- Sherbrooke Park Advisers's biggest Q2 2025 reduction was MasTec, cutting an estimated $947K.
- Sherbrooke Park Advisers fully exited Merck in Q2 2025, selling an estimated $1.44M.
- Sherbrooke Park Advisers's ten largest holdings make up 7% of its $230M portfolio in Q2 2025.
- Sherbrooke Park Advisers opened 263 new positions and closed 324 in Q2 2025.
- Sherbrooke Park Advisers's portfolio value rose 7.3% quarter-over-quarter to $230M.
Based on Sherbrooke Park Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.